EarningsQ4 2024 Earnings Report

Jazz Pharmaceuticals (JAZZN) Q4 2024 Earnings Report

0 Followers

MX:JAZZN Q4 2024 EPS Results

Actual EPS$118.55

Consensus EPS$105.30

Beat/MissBeat by +$13.26

One Year Ago EPS$90.17

Actual Revenue$19.55B

Expected Revenue$19.01B

Beat/MissBeat by +$539.77M

YoY Revenue Growth+7.53%

QuarterQ4 2024

Date02/25/2025

TimeAfter Close

Conference CallTuesday, February 25, 2025

MX:JAZZN Upcoming Earnings

Jazz Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:JAZZN Q4 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	115.73 / -	146.034	―
Aug 03, 2026	2026 (Q2)	110.92 / 102.57	-148.189	169.21% (+250.75)
May 05, 2026	2026 (Q1)	83.36 / 113.88	30.177	277.38% (+83.70)
Feb 24, 2026	2025 (Q4)	117.08 / 119.27	118.552	0.61% (+0.72)
Nov 05, 2025	2025 (Q3)	106.80 / 146.03	118.731	23.00% (+27.30)
Aug 05, 2025	2025 (Q2)	-136.62 / -148.19	95.2	-255.66% (-243.39)
May 06, 2025	2025 (Q1)	83.67 / 30.18	48.139	-37.31% (-17.96)
Feb 25, 2025	2024 (Q4)	105.30 / 118.55	90.171	31.47% (+28.38)
Nov 06, 2024	2024 (Q3)	98.76 / 118.73	86.938	36.57% (+31.79)
Jul 31, 2024	2024 (Q2)	88.41 / 95.20	81.01	17.52% (+14.19)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed